Comparison of seroepidemiology and transmission modes of viral hepatitis C in Iran and Pakistan

Hepatitis Monthly

Volumn 8, Issue 1, 2008, Pages 51-59

  Alavian, Seyed Moayed ^a   Fallahian, Farahnaz ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis C; Prevention; Review; Seroprevalence; Tranmission

Indexed keywords

COMPARATIVE STUDY; EMBASE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GOVERNMENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; IRAN; MEDLINE; NONHUMAN; PAKISTAN; REVIEW; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEXUAL INTERCOURSE; TATTOO; VIRUS TRANSMISSION; WAR;

EID: 44949143241     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16.
2. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777-82.
3. Khan AA. Endemic Transmission of Hepatitis C. J Coll Physicians Surg Pak 1995; 5: 11-3.
4. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
5. Alavian SM, Adibi P, M.R. Z. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med 2005; 8: 84-90.
6. Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997; 119: 349-56.
7. Parker SP, Khan HI, Cubitt WD. Detectio of antibodies to hepatitis C virus in dried blood spot samples from motheys and their offspring in Lahore, Pakistan. J Clin Microbiol 1999; 37: 2061-3.
8. Ehokhar N, Gill ML, Malik GJ. General seroprevafence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004; 14: 534-6.
9. Ali N, Khattak J, Anwar M. Prevalence of hepatitis B surface antigen and hepatitis C antibodies in young healthy adults. Pak J Pathol 2002; 13: 3-6.
10. Hamid S, Umar M, Alam A, Siddiqui A Qureshi H, Butt J. PSG consensus statement on management of hepatitis C virus infection - 2003. J Pak Med Assoc 2004; 54: 146-50.
11. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 2002; 52: 398-402.
12. Mujeeb SA, Mehmood K. Prevalence of HBV, HCV, and HIV infections among family blood donors. Ann Saudi Med 1996; 16: 702-3.
13. Kakepoto GN, Bhally HS, Khahq G, Kayani N, Burney IA, Siddiqui T, et al. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health 1996; 27: 703-6.
14. Bashawri LA, Fawaz NA, Abroad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol 2004; 26: 225-8.
15. Akhtar S, Younus M, Adil S, Jafri SH, Hapsan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat 2004; 11: 527-35.
16. Abdul Mujeeb S, Aamir K, Mehmood K. Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc 2000; 50: 269-70.
17. Asif N, Khokhar N, Ilahi F. Seroprevalence of HBV, HCV and HIV infection among voluntary non remunerated and replacement donors in Northern Pakistan. Pak J Med Sci 2004; 20: 24-8.
18. Ali N, Nadeem M, Qamar A, Qureshi AH, Ejaz A. Frequency of hepatitis-C virus antibodies in blood donors in Combined Military Hospital, Quetta. Pak J Med Sci 2003; 19: 41-4.
19. Luby S, Khanani R, Zia M, Vellani Z, Ali M, Qureshi AH, et al. Evaluation of blood bank practices in Karachi Pakistan, and the government's response. J Pak Med Assoc 2006; 56: S25-30.
20. Luby SP, Niaz Q, Siddiqui S, Mujeeb SA, Fisher-Hoch S. Patients' perceptions of blood transfusion risks in Karachi, Pakistan. Int J Infect Dis 2001; 5: 24-6.
21. Aslam M, Aslam J. Seroprevalence, of the antibody to hepatitis C in select groups in the Punjab region of Pakistan. J Clin Gastroenterol 2001; 33: 407-11.
22. Muhammad N, Jan MA. Frequency of hepatitis "C" in Buner, NWFP. J Coll Physicians Surg Pak 2005; 15: 11-4.
23. Aziz S, Memon A Tily HI, Rasheed K, Jehangir K, Quraishy, MS. Preyalence of HIV, hepafitis B and C amongst hea4th workers of Civil Hospital Karachi. J Pak Med Assoc 2006; 56: S48-50.
24. Aziz AB, Hamid S, Iqbal S, Islam W; Karim SA. Prevalence and severity of viral hepatitis in Pakistani pregnant women: a five year hospital based study. J Pak Med Assoc 1997; 47: 198-201.
25. Abdul Mujeeb S, Jamal Q, Khanam R, Iqbal N, Kaher S, Prevalence of hepatitis B surface antigen' and antibodies in hepatocellular carcinoma cases in Karachi Pakistan. Trop Doct 1997; 27: 46-6.
26. Tong CY, Khan R, Beeching NJ, Tariq WU, Hart CA, Ahmad N, et al. The oacurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellula carcinoma. Epidemiol Infect 1996; 117: 327-32.
27. Malik IA, Ahmad N, Luqman M, Legters LJ, Khalil U, Zaheeruddin, et al. Hepatitis C as a cause of chronic liver disease in northern Pakistan. J Pak Med Assoc 1992; 42: 67-8.
28. Khan AA, Rehman K, Haider Z, Shafqat F. Seromarkers of Hepatitis B and C in patients with Cirrhosis. J Coll Physicians Surg Pak 2002; 12: 105-7.
29. Chohan AR, Umar M, Khaar B, Ehurram M, Zahid M, Shah SF. Demographic features of hepatocellular carcinoma: a study of 30 cases. J Rawal Med Coll 2001; 5: 81-3.
30. Shaikh MA, Shaikh WM, Solangi GA, Abro H. Frequency and transmission mode of hepatitis C virus in northern Sindh. J Coll Physicians Surg Pak 2003; 13: 691-3.
31. Mahmood A, Karamat KA, Mubarik K, Rehman ZU. Prevalence of hepatitis C virus antibodies in cases of chronic hepatitis and cirrhosis at PNS Shifa, Karachi. Pak Armed Forces Med J 1999; 49: 15-7.
32. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Org 2000; 78: 956-63.
33. Rezvan H, Ahmadi J, Farhadi M. A preliminary study on the prevalence of anti-HCV among healthy blood donors in Iran. Vox Sang 1994; 67: 100.
34. Ebrahim-Poor S YM, Gharamaleki V, Khoshvar H, Sakhinia E, Madadi A Seroepidemiological studies of hepatitis B and C in hemophilics in north-western, Iran. Iran J Med Sci 1997; 22: 126.
35. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002; 17: 1092-7.
36. Haidar NA. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J 2002; 23: 1090-4.
37. al-Faleh FZ, Ayoola EA, al-Jeffry M, al-Rashed R, al-Mofarreh M, Arif M, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology 1991; 14: 215-8.
38. al-Faleh FZ, Ramia S, Arif M, Ayoola EA, al-Rashed RS, al-Jeffry M, et al. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan area of Saudi Arabia: a community-based study. Ann Trop Med Parasitol 1995; 89: 431-7.
39. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Risk factors for hepatocellular carcinoma in Southern Iran. Saudi Med J 2005; 26: 974-7.
40. Bagheri-Lankarani K, Saberi-Firoozi M, Nabipoor I. Reassessment of the role of hepatitis B and C viruses in postnecrotic cirrhosis and chronic hepatitis in southern Iran. Iran J Med Sci 1999; 24: 119-21.
41. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231-5.
42. Nuchprayoon T, Chumnijarakij T. Risk factors for hepatitis B carrier status among blood donors of the National Blood Center, Thai Red Cross Society. Southeast Asian J Trop Med Public Health 1992; 23: 246-53.
43. Scaraggi FA, Lomuscio S, Perrici A, De Mitrio V, Napoli N, Schiraldi O. Intrafamilial and sexual transmission of hepatitis C virus. Lancet 1993; 342: 1300-2.
44. MacDonald V, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev 1996; 18: 137-48.
45. Koerner K, Cardoso M, Dengler T, Kerowgan M, Kubanek B. Estimated risk of transmission of hepatitis C virus by blood transfusion. Vox Sang 1998; 74: 213-6.
46. Donahue JG, Munoz A, Ness PM, Brown DE, Jr., Yawn DH, McAllister HA, Jr., et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-73.
47. Bari A, Akhtar S, Rahbar MH, Luby SP. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop Med Int Health 2001; 6: 732-8.
48. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, et al. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis 1995; 27: 441-4.
49. Tumminelli F, Marcellin P, Rizzo S, Barbera S, Corvino G, Furia P, et al. Shaving as potential source of hepatitis C virus infection. Lancet 1995; 345: 658.
50. Mujeeb SA, Shahab S, Hyder AA. Geographical display of health information: study of hepatitis C infection in Karachi, Pakistan. Public Health 2000; 114: 413-5.
51. Sultan F, Mehmood T, Mahmood MT. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Int J Infect Dis 2007; 11: 407-12.
52. Akhtar S, Younus M, Adil S, Hassan F, Jafri SH. Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan. BMC Gastroenterol 2005; 5: 26.
53. Mujeeb SA. Unsafe injections: a potential source of HCV spread in Pakistan. J Pak Med Assoc 2001; 51: 1-3.
54. Mujeeb SA, Khatri Y, Khanani R. Frequency of parenteral exposure and seroprevalence of HBV, HCV, and HIV among operation room personnel. J Hosp Infect 1998; 38: 133-7.
55. Ahmad K. Pakistan: a cirrhotic state? Lancet 2004; 364: 1843-4.
56. Fingerhood MI, Jasinski DR, Sullivan JT. Prevalence of hepatitis C in a chemically dependent population. Arch Intern Med 1993; 153: 2025-30.
57. Maayan S, Shufman EN, Engelhard D, Shouval D. Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem. Addiction 1994; 89: 869-74.
58. Woodfield DG, Harness M, Rix-Trott K. Hepatitis C virus infections in oral and injectable drug users. N Z Med J 1993; 106: 332-4.
59. Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Kawakami Y, Akazawa K, et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995; 90: 794-9.
60. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-6.
61. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of ioodborne pathogens: a review. Bull World Health Org 1999; 77: 789-800.
62. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Org 1999; 77: 801-7.
63. Yee LJ, Weiss HL, Langner RG, Herrera J, Kaslow RA, van Leeuwen DJ. Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infect Dis 2001; 1: 8.
64. Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SF, Jafar T, et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006; 6: 101.
65. Wang CS, Wang ST, Chang TT, Yao, WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162: 8 11-5.
66. Jaffery T, Tariq N, Ayub R, Yawar A. Frequency of hepatitis C in pregnancy and pregnancy outcome. J Coll Physicians Surg Pak 2005; 15: 716-9.
67. Agboatwalla M, Isomura S, Miyake K, Yamashita T, Morishita T, Akram DS. Hepatitis A, B and C seroprevalence in Pakistan. Indian J Pediatr 1994; 61: 545-9.
68. Akhtar S, Moatter T. Multilevel modeling of intra-household \ spread of hepatitis C virus infection, Karachi, Pakistan. Am J Trop Med Hyg 2007; 76: 446-9.
69. Tibbs CJ. Methods of transmission of hepatitis C. J Viral Hepat 1995; 2: 113-9.
70. Ackerman Z, Ackerman E, Paltiel O. Intrafamilial transmission of hepatitis G virus: a systematic review. J Viral Hepat 2000; 7: 93-103.
71. Akhtar S, Moatter T. Intra-househoid clustering of hepatitis C virus infection in Karachi, Pakistan. Trans R Soc Trop Med Hyg 2004; 98: 535-9.
72. Mohtasham Amiri Z, Rezvani M, Jafari Shakib R, Jafari Shakib A. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. East Mediterr Health J 2007; 13: 250-6.
73. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Kbuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol 2006; 12: 4884-7.
74. Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan - Iran. World J Gastroenterol 2005; 11: 4085-9.
75. Hosseini-Asl SK, Avijgan M, Mohamadnejad M. High prevalence of HBV, HCV, and HIV infections in gypsy population residing in Shahr-e-Kord. Arch Iranian Med 2004; 7: 20-2.
76. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol 2006; 12: 7025-8.
77. Shah HA, Jafri W, Malik I, Prescott L, Simmonds P. Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol 1997; 12: 758-61.
78. Zuberi SJ, Arif A. Serotyping of the hepatitis C in Pakistan. J Pak Med Assoc 2002; 52: 218-9.
79. Moatter T, Hussainy AS, Hamid S, Ahmad Z, Siddiqui S. Comparative analysis of viral titers and histologic features of Pakistani patients infected with hepatitis C virus type 3. Int J Infect Dis 2002; 6: 272-6.
80. Khokhar N, Asif N, Khokhar OS. Serotype 3 is most common hepatitis C serotype in Pakistan: however, significant numbers are untypeable. Hepatology 2003; 38: 270-1.
81. Kabir A, Alavian SM, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol 2006; 5: 4.
82. Samimi-Rad K, Nategh R, Malekzadeb R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol 2004; 74: 246-52.
83. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res 2007; 37: 101-3.
84. Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SF, Jafar T, et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006; 6: 101.
85. Mele A, Corona R, Tosti ME, et al. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis 1995; 27: 441-4.